# Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients

> **NCT00981591** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Seattle Children's Hospital**

## Conditions studied

- Pulmonary Hypertension
- Neonatal Hypoxic Respiratory Failure
- Persistent Pulmonary Hypertension of Newborn
- Congenital Heart Defects
- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Iloprost
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00981591
- **Lead sponsor:** Seattle Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-09
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients recruited
- **Last updated:** 2015-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00981591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00981591, "Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00981591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*